Treprostinil in advanced experimental pulmonary hypertension: Beneficial outcome without reversed pulmonary vascular remodeling

ME van Albada, Richard van Veghel, AH Cromme-Dijkhuis, RG (Regien) Schoemaker, RFME Berger

Research output: Contribution to journal › Article › Academic › peer-review

16 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	249-254
Number of pages	6
Journal	Journal of Cardiovascular Pharmacology
Volume	48
Issue number	5
DOIs	https://doi.org/10.1097/01.fjc.0000248229.87510.9b
Publication status	Published - 2006

Research programs

@article{bb3eebc4d3aa4bbcbea93a2f0f6c693b,

title = "Treprostinil in advanced experimental pulmonary hypertension: Beneficial outcome without reversed pulmonary vascular remodeling",

author = "{van Albada}, ME and {van Veghel}, Richard and AH Cromme-Dijkhuis and Schoemaker, {RG (Regien)} and RFME Berger",

year = "2006",

doi = "10.1097/01.fjc.0000248229.87510.9b",

language = "Undefined/Unknown",

volume = "48",

pages = "249--254",

journal = "Journal of Cardiovascular Pharmacology",

issn = "0160-2446",

publisher = "Lippincott Williams & Wilkins",

number = "5",

}

TY - JOUR

T1 - Treprostinil in advanced experimental pulmonary hypertension: Beneficial outcome without reversed pulmonary vascular remodeling

AU - van Albada, ME

AU - van Veghel, Richard

AU - Cromme-Dijkhuis, AH

AU - Schoemaker, RG (Regien)

AU - Berger, RFME

PY - 2006

Y1 - 2006

U2 - 10.1097/01.fjc.0000248229.87510.9b

DO - 10.1097/01.fjc.0000248229.87510.9b

M3 - Article

C2 - 17110807

SN - 0160-2446

VL - 48

SP - 249

EP - 254

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

IS - 5

ER -